Stock IMNM IMMUNOME, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Immunome, Inc.

Equities

IMNM

US45257U1088

Real-time Estimate Cboe BZX
Other stock markets
 10:08:17 2024-05-21 am EDT 		5-day change 1st Jan Change
13.9 USD +0.72% Intraday chart for Immunome, Inc. -4.59% +31.26%
May. 20 Immunome Completes Purchase of Antibodies From Atreca MT
May. 17 Immunome Appoints Max Rosett as CFO MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Immunome Completes Purchase of Antibodies From Atreca
MT
Immunome Promotes Max Rosett to Chief Financial Officer
AQ
Immunome Announces Completion of Purchase of Assets from Atreca
BU
Immunome, Inc. completed the acquisition of Substantially all Assets of Atreca, Inc..
CI
Immunome Appoints Max Rosett as CFO
MT
Immunome Announces Promotion of Max Rosett to Chief Financial Officer
BU
Immunome, Inc. Announces Promotion of Max Rosett to Chief Financial Officer
CI
Immunome Reports First Quarter 2024 Financial Results and Provides Business Update
BU
Immunome, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Certain Common Stock of Immunome, Inc. are subject to a Lock-Up Agreement Ending on 14-MAY-2024.
CI
Certain Warrants of Immunome, Inc. are subject to a Lock-Up Agreement Ending on 14-MAY-2024.
CI
Certain Stock Options of Immunome, Inc. are subject to a Lock-Up Agreement Ending on 14-MAY-2024.
CI
Immunome to Present at 2024 Bank of America Healthcare Conference
BU
Immunome Appoints Kinney Horn as Chief Business Officer
BU
Immunome, Inc. Appoints Kinney Horn as Chief Business Officer
CI
JPMorgan Starts Immunome With Overweight Rating, $24 Price Target
MT
Immunome Appoints Sandra M. Swain to Board of Directors
BU
Immunome, Inc. Appoints Sandra M. Swain to Board of Directors
CI
Guggenheim Starts Immunome With Buy Rating, $35 Price Target
MT
Immunome to Present Preclinical Data for IM-3050, Its Lead Radioligand Therapy Candidate, at 2024 American Association for Cancer Research Annual Meeting
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. IMNM Stock
  4. News Immunome, Inc.
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW